Forza Wealth Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$632K Hold
4,999
0.19% 110
2026
Q1
$697K Hold
4,999
0.24% 98
2025
Q4
$614K Hold
4,999
0.22% 110
2025
Q3
$555K Hold
4,999
0.21% 110
2025
Q2
$554K Sell
4,999
-130
-3% -$13.8K 0.23% 110
2025
Q1
$575K Buy
5,129
+75
+1% +$7.74K 0.26% 101
2024
Q4
$467K Hold
5,054
0.21% 111
2024
Q3
$424K Buy
5,054
+337
+7% +$25.7K 0.19% 134
2024
Q2
$324K Hold
4,717
0.17% 139
2024
Q1
$346K Sell
4,717
-100
-2% -$7.69K 0.18% 136
2023
Q4
$390K Sell
4,817
-300
-6% -$23.3K 0.22% 127
2023
Q3
$383K Hold
5,117
0.2% 132
2023
Q2
$394K Hold
5,117
0.2% 132
2023
Q1
$425K Hold
5,117
0.22% 133
2022
Q4
$439K Buy
+5,117
New +$405K 0.29% 92

Other funds holding GILD

Forza Wealth Management's GILD Position: Q2 2026 in Review

Forza Wealth Management held its Gilead Sciences (GILD) position steady in Q2 2026 at 4,999 shares worth $632K. The position accounts for 0.19% of the portfolio, ranked #110.

Forza Wealth Management first reported a position in GILD in Q4 2022 and has held it in 15 quarters since. The position peaked at $697K in Q1 2026. 428 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Forza Wealth Management held 4,999 shares of Gilead Sciences worth $632K as of Q2 2026.
  • Forza Wealth Management left its Gilead Sciences share count unchanged in Q2 2026.
  • Gilead Sciences made up 0.19% of Forza Wealth Management's portfolio in Q2 2026, its #110 holding.
  • Forza Wealth Management first reported a position in Gilead Sciences in Q4 2022 and has held it in 15 quarters since.
  • Forza Wealth Management's Gilead Sciences position peaked at $697K in Q1 2026.
  • 428 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Forza Wealth Management's 13F filing for Q2 2026, filed 17 Jul 2026.